United States · How much has ReNAgade Therapeutics raised?
ReNAgade Therapeutics has raised $300M across 1 round since 2023.
United States · Series A startup
Who invested in ReNAgade Therapeutics
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow ReNAgade Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$300Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $300MMay 2023
- Investors
- 0
The rounds
- May 2023Series A$300M
No investor was named in the report.
Source recorded
Quick answers about ReNAgade Therapeutics
When did ReNAgade Therapeutics last raise?
ReNAgade Therapeutics's most recent round was a Series A of $300M in May 2023.
What was ReNAgade Therapeutics's biggest round?
Its most recent round, $300M in May 2023, is also its largest on record.
What stage is ReNAgade Therapeutics at?
ReNAgade Therapeutics's latest named round is a Series A, in May 2023.
Where is ReNAgade Therapeutics based?
ReNAgade Therapeutics is based in the United States.
Companies like ReNAgade Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.